Ventas $500 million senior notes offering
We advised Ventas on its investment-grade debt offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
RxSight $115 million follow-on offering
The stock is listed on the Nasdaq Global Market
NatWest Group $1 billion contingent convertible Additional Tier 1 notes
We advised NatWest Group on the SEC-registered offering
Oculis Holding $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
Meritage Homes $575 million convertible notes offering
The 1.75% convertible senior notes are due 2028
SS&C Technologies $750 million senior notes offering
We advised SS&C Technologies on the high-yield debt offering
ZEEKR Intelligent Technology $441 million IPO
We advised ZEEKR on its IPO and NYSE listing
Mastercard $1 billion senior notes offering
We advised Mastercard on its investment-grade debt offering
Visa Class B stockholder liquidity program and $100 billion exchange offer
We advised Visa on the design and implementation of its Class B stockholder liquidity program and inaugural exchange offer